<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Creighton RL</submitter><funding>NSF</funding><funding>Eunice Kennedy Shriver National Institute of Child Health and Human Development</funding><funding>NICHD NIH HHS</funding><funding>NIDCR NIH HHS</funding><funding>NIAID NIH HHS</funding><funding>National Institutes of Health</funding><funding>NIH</funding><funding>Molecular Engineering and Sciences Institute, University of Washington</funding><funding>University of Washington</funding><funding>National Institute of Dental and Craniofacial Research</funding><funding>Washington Research Foundation</funding><funding>Clean Energy Institute</funding><funding>National Science Foundation</funding><pagination>649-660</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11010722</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>367</volume><pubmed_abstract>The oral mucosa is an attractive site for immunization due to its accessibility and ability to elicit local and systemic immune responses. However, evaluating oral mucosal immunogenicity has proven challenging due to the physical barriers and immunological complexity of the oral mucosa. Microneedles can overcome these physical barriers, but previous work has been limited in the scope of microneedle delivery site, geometry, and release kinetics, all of which are expected to affect physiological responses. Here, we develop integrated fiber microneedle devices, an oral dosage form with tunable geometries and material configurations capable of both burst and sustained release to controlled depths in the oral mucosa. Integrated fiber microneedles administered to either the buccal or sublingual </pubmed_abstract><journal>Journal of controlled release : official journal of the Controlled Release Society</journal><pubmed_title>Oral mucosal vaccination using integrated fiber microneedles.</pubmed_title><pmcid>PMC11010722</pmcid><funding_grant_id>DP2 HD075703</funding_grant_id><funding_grant_id>DGE-1256082</funding_grant_id><funding_grant_id>T32 AI007140</funding_grant_id><funding_grant_id>DP2HD075703</funding_grant_id><funding_grant_id>R56 DE028539</funding_grant_id><funding_grant_id>1R56DE028539</funding_grant_id><funding_grant_id>2T32AI007140-41</funding_grant_id><pubmed_authors>Doan MA</pubmed_authors><pubmed_authors>Woodrow KA</pubmed_authors><pubmed_authors>Creighton RL</pubmed_authors><pubmed_authors>Tobos CI</pubmed_authors><pubmed_authors>Guo T</pubmed_authors><pubmed_authors>Faber KA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Oral mucosal vaccination using integrated fiber microneedles.</name><description>The oral mucosa is an attractive site for immunization due to its accessibility and ability to elicit local and systemic immune responses. However, evaluating oral mucosal immunogenicity has proven challenging due to the physical barriers and immunological complexity of the oral mucosa. Microneedles can overcome these physical barriers, but previous work has been limited in the scope of microneedle delivery site, geometry, and release kinetics, all of which are expected to affect physiological responses. Here, we develop integrated fiber microneedle devices, an oral dosage form with tunable geometries and material configurations capable of both burst and sustained release to controlled depths in the oral mucosa. Integrated fiber microneedles administered to either the buccal or sublingual </description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Mar</publication><modification>2025-04-04T10:42:12.404Z</modification><creation>2025-04-04T10:42:12.404Z</creation></dates><accession>S-EPMC11010722</accession><cross_references><pubmed>38295993</pubmed><doi>10.1016/j.jconrel.2024.01.062</doi></cross_references></HashMap>